4Hampel H, Goernitz A, Buerger K. Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and Abeta (1-42) proteins to phospho rylated tau protein. Brain Res Bull 2003;61(3):243-53.
5Baksalerska-Pazera M, Niewiadomska G.Structure and role of the tau protein.Postepy Biochem 2002,48(4):287-95.
6Kvetnoi IM, Kvetnaia TV, Riadnova IIu, et al. Expression of beta-amyloid and tau-protein in mastocvtes in Alzheimer disease.Arkh Patol 2003,65(1):36-9.
7Lewczuk P, Esselmann H, Bibl M. et al. Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzbeimer's disease: original data and review of the literature. J Mol Neurosci 2004,23(1-2):115-22.
8Rossi G, Giaccone G, Maletta R, et rd. A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene. Neurology 2004;63(5):910-2.
9Gordon MN, Holcomh LA, Jantzen PT, et al. Time course of the development of Alzheimer-like pathology in the douhly transgenic PSI+APP mouse. Exp Neurol 2002,173(2): 183-95.
10McCarron MO, Delong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerehrovascular disease: a meta-analvsis.Neurology 1999,53(6): 1308-11.
9Lewis B. Morgenstem,J. Claude Hemphill Ⅲ,Craig Anderson,Kyra Becker,Joseph P. Broderick,E. Sander Connolly Jr,Steven M. Greenberg,James N. Huang,R. Loch Macdonald,Steven R. Messe,Pamela H. Mitchell,Magdy Selim,Rafael J. Tamargo,王玉洁(译),王健(译),刘相玉(译),谢丽丽(译).自发性脑出血治疗指南美国心脏协会／美国卒中协会对医疗卫生专业人员发布的指南[J].国际脑血管病杂志,2010(8):561-580. 被引量：262
